Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise
F Yin - The FEBS journal, 2023 - Wiley Online Library
Alzheimer's disease (AD) is an age‐associated neurodegenerative disorder with
multifactorial etiology, intersecting genetic and environmental risk factors, and a lack of …
multifactorial etiology, intersecting genetic and environmental risk factors, and a lack of …
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
GJ Biessels, F Despa - Nature Reviews Endocrinology, 2018 - nature.com
Cognitive dysfunction is increasingly recognized as an important comorbidity of diabetes
mellitus. Different stages of diabetes-associated cognitive dysfunction exist, each with …
mellitus. Different stages of diabetes-associated cognitive dysfunction exist, each with …
[HTML][HTML] New insights into the genetic etiology of Alzheimer's disease and related dementias
Abstract Characterization of the genetic landscape of Alzheimer's disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …
dementias (ADD) provides a unique opportunity for a better understanding of the associated …
[HTML][HTML] Alzheimer's disease prevention: from risk factors to early intervention
M Crous-Bou, C Minguillón, N Gramunt… - Alzheimer's research & …, 2017 - Springer
Due to the progressive aging of the population, Alzheimer's disease (AD) is becoming a
healthcare burden of epidemic proportions for which there is currently no cure …
healthcare burden of epidemic proportions for which there is currently no cure …
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez… - Nature …, 2017 - nature.com
We identified rare coding variants associated with Alzheimer's disease in a three-stage case–
control study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole …
control study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole …
Vascular cognitive impairment
WM Van Der Flier, I Skoog, JA Schneider… - Nature reviews Disease …, 2018 - nature.com
The term vascular cognitive impairment (VCI) was introduced around the start of the new
millennium and refers to the contribution of vascular pathology to any severity of cognitive …
millennium and refers to the contribution of vascular pathology to any severity of cognitive …
Alzheimer's disease
Although the prevalence of dementia continues to increase worldwide, incidence in the
western world might have decreased as a result of better vascular care and improved brain …
western world might have decreased as a result of better vascular care and improved brain …
The changing prevalence and incidence of dementia over time—current evidence
Dementia is an increasing focus for policymakers, civil organizations and multidisciplinary
researchers. The most recent descriptive epidemiological research into dementia is …
researchers. The most recent descriptive epidemiological research into dementia is …
Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
CSF biomarkers, including total-tau, neurofilament light chain (NfL) and amyloid-β, are
increasingly being used to define and stage Alzheimer's disease. These biomarkers can be …
increasingly being used to define and stage Alzheimer's disease. These biomarkers can be …
[HTML][HTML] Secondary nucleation in amyloid formation
M Törnquist, TCT Michaels, K Sanagavarapu… - Chemical …, 2018 - pubs.rsc.org
Nucleation of new peptide and protein aggregates on the surfaces of amyloid fibrils of the
same peptide or protein has emerged in the past two decades as a major pathway for both …
same peptide or protein has emerged in the past two decades as a major pathway for both …